CENTRAL GARDEN & PET CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CENTRAL GARDEN & PET CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,829	2,054	2,215	2,383	2,696	3,304	3,339	3,310	3,201	3,129
Cost of revenue	1,276	1,422	1,540	1,679	1,899	2,333	2,346	2,363	2,257	2,132
Gross profit	553	633	675	704	797	971	992	947	944	997
Selling, general and administrative	422	477	508	552	599	716	732	736	758	747
Operating income	129	156	167	152	198	254	260	211	185	250
Interest expense	42.8	28.2	39.2	42.6	44	58.6	58.3	57	57.5	57.7
Interest income	0.14	0.15	3.15	9.55	4.03	0.42	0.72	7.36	19.7	24.9
Other non-operating income	-17	-1.62	-3.86	0.24	-4.25	-1.51	-3.6	1.46	-5.09	-0.48
Pre-tax income	69.6	126	127	119	154	195	199	162	142	217
Income tax	24.1	46.7	3.31	26.6	32.2	42	46.2	36.3	33.1	52.8
Net income to minority interests	1.07	0.9	0.53	-0.14	0.84	1.03	0.52	0.45	1.33	1.12
Net income	44.5	78.8	124	92.8	121	152	152	126	108	163
EBITDA	169	199	215	203	253	329	341	298	276	335
EPS, basic	0.73	1.26	1.91	1.30	1.78	2.25	2.29	1.92	1.64	2.58
EPS, diluted	0.70	1.22	1.86	1.29	1.76	2.20	2.24	1.88	1.62	2.55
Shares, basic (weighted)	61.2	62.8	64.6	71	67.5	67.4	66.5	65.5	65.7	63.1
Shares, diluted (weighted)	63.8	64.8	66.7	72	68.4	69.1	68	66.8	66.9	63.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	93	32.4	482	498	653	426	177	489	754	882
Short-term investments			0	0
Receivables	201	238	276	300	392	385	377	333	326	325
Inventory	362	382	428	466	440	685	938	838	758	722
Other current assets	16.2	18	20.6	30.2	27.5	33.5	46.9	33.2	34.2	30.3
Total current assets	683	683	1,217	1,307	1,525	1,544	1,554	1,707	1,887	1,976
Property, plant and equipment	158	181	218	245	245	329	397	392	379	363
Lease right-of-use assets					116	166	186	174	205	223
Goodwill	231	256	281	286	290	369	546	546	551	555
Intangible assets	95.9	116	152	146	135	134	543	497	473	448
Other non-current assets	11.9	70.6	38.8	40.2	28.7	575	55.2	62.6	57.7	61.1
Total assets	1,181	1,307	1,907	2,025	2,339	3,117	3,282	3,379	3,553	3,626
Accounts payable	102	103	110	149	205	246	216	191	213	235
Accrued liabilities	99.3	117	103	129	201	235	202	216	245	247
Short-term debt	0.46	0.38	0.12	0.11	0.1	1.08	0.32	0.25	0.24	0.06
Total current liabilities	202	220	213	279	440	522	466	458	515	539
Long-term debt	395	395	692	693	694	1,185	1,186	1,188	1,190	1,192
Lease liabilities					86.5	130	148	136	173	192
Other non-current liabilities	29.1	54.3	49.4	57.3
Total liabilities	626	670	954	1,029	1,262	1,893	1,947	1,926	1,996	2,041
Total debt	395	396	692	693	694	1,186	1,187	1,188	1,190	1,192
Paid-in capital	393	397	590	575	567	576	582	594	598	571
Retained earnings	161	239	363	422	511	646	755	859	960	1,015
Other comprehensive income	-1.29	-0.95	-1.22	-1.68	-1.41	-0.83	-4.15	-2.97	-2.63	-3.85
Shareholders' equity	553	636	952	996	1,077	1,222	1,334	1,451	1,556	1,583
Minority interests	1.57	1.46	0.39	0.17	0.87	1.29	1.01	1.46	1.89	1.67
Total equity	555	637	953	996	1,078	1,224	1,335	1,453	1,558	1,585
Total liabilities and equity	1,181	1,307	1,907	2,025	2,339	3,117	3,282	3,379	3,553	3,626

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	45.6	79.7	124	92.6	122	153	153	126	109	164
Depreciation and amortization	40	42.7	47.2	50.8	55.4	74.7	80.9	87.7	90.8	84.9
Stock-based compensation	8.36	11.1	11.6	14.7	19	23.1	25.8	28	20.6	21.1
Deferred income tax	3.19	10.8	-4.83	6.66	-6.62	-14.7	28.1	-12.3	-14.5	-2.1
Change in receivables	27.4	-32.4	-28.7	1.49	-91.5	69.1	7	44	11.9	0.63
Change in inventory	-6.52	-15.9	-15.1	-3.7	27.4	-132	-256	87	84.3	31.3
Change in payables	-2.79	-2.14	-1.16	30.5	52	24.6	-31.2	-20	18.4	20.1
Cash from operations	151	114	114	205	264	251	-34	382	395	333
Capital expenditures	-27.6	-44.7	-37.8	-31.6	-43.1	-80.3	-115	-54	-43.1	-41.4
Acquisitions			-91.2	-41.2	0	-820	0	0	-60.2	-3.32
Purchases of investments	0	0
Cash from investing	-91.2	-163	-141	-76.3	-48.1	-899	-143	-34.6	-105	-44.9
Debt issued	400	0	300	0	0	900	0	0
Debt repaid	-400	-0.46	-0.43	-46.2	-0.11	-430	-1.1	-0.34	-0.37	-0.23
Stock issued	0.32	0	196	0	0			0	0	0
Share buybacks	-10.9	-27.6	-13.8	-63	-59.1	-27.9	-62.3	-37.2	-24.1	-155
Cash from financing	-14.2	-10.4	475	-111	-60.6	420	-66.8	-37.6	-25.4	-157
Exchange rate effect	-0.67	0.08	-0.05	-0.25	0.09	1.17	-3.51	1.19	1.26	-0.95
Net change in cash	45.4	-58.9	448	17.7	156	-227	-247	311	266	130
Free cash flow	124	69.7	76.3	173	221	171	-149	328	352	291
Interest paid	33	27.9	36.7	42.7	43.9	42.8	57.9	57.1	57.5	57.7
Income taxes paid	10.4	10.6	19.5	15	25.5	70.8	35	17.9	53.6	61.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $39.51 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.5%	Gross profit / revenue.
Operating margin	8.1%	Operating income / revenue.
EBITDA margin	10.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.1%	Pre-tax income / revenue.
Net margin	5.4%	Net income / revenue.
FCF margin	11.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.7%	Cash from operations / revenue.
Effective tax rate	24.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.4%	Net income / average total assets.
Return on invested capital (ROIC)	9.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	24.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.4%	Capital expenditures / revenue.
D&A / revenue	2.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	34.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-1.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	4.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	21.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	5.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	50.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	2.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	6.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	57.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	4.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	7.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-15.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	4.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-17.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	5.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	8.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	9.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.79x	Current assets / current liabilities.
Quick ratio	2.58x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.77x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.68x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	31.5%	Total debt / total assets.
Liabilities / assets	53.9%	Total liabilities / total assets.
Net debt	$196.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.59x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$1.57B	Current assets - current liabilities.
Goodwill and intangibles / assets	25.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$772.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.81x	Revenue / average total assets.
Fixed asset turnover	8.83x	Revenue / average property, plant and equipment.
Inventory turnover	3.29x	Cost of revenue / average inventory.
Days inventory	111 days	365 x average inventory / cost of revenue.
Receivables turnover	6.70x	Revenue / average receivables.
Days sales outstanding	54 days	365 x average receivables / revenue.
Days payables	38 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	127 days	Days inventory + days sales outstanding - days payables.
FCF conversion	207.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.68	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$49.79	Revenue / diluted weighted shares.
FCF per share	$5.58	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.30	Cash from operations / diluted weighted shares.
Book value per share	$28.18	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$12.48	Tangible book value / shares outstanding.
Cash per share	$16.09	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	8.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.47B	Share price x shares outstanding.
Enterprise value	$2.67B	Market cap + total debt - cash - short-term investments.
P/E	14.9x	Market cap / net income. Only when net income is positive.
P/S	0.80x	Market cap / revenue.
P/B	1.42x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.20x	Market cap / tangible book value, when positive.
P/FCF	7.16x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.34x	Market cap / cash from operations, when positive.
EV/Sales	0.87x	Enterprise value / revenue.
EV/EBIT	10.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.05x	Enterprise value / EBITDA, when both are positive.
EV/FCF	7.72x	Enterprise value / free cash flow, when both are positive.
FCF yield	14.0%	Free cash flow / market cap.
Earnings yield	6.7%	Net income / market cap (the inverse of P/E).
Shareholder yield	1.2%	(Dividends paid + share buybacks) / market cap.
PEG	3.37x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CENTRAL GARDEN & PET CO's revenue in fiscal 2025?

CENTRAL GARDEN & PET CO reported revenue of $3.13B for fiscal 2025, 2.2% lower than the year before.

Was CENTRAL GARDEN & PET CO profitable in fiscal 2025?

Yes. Net income was $162.8M, a net margin of 5.2%.

How much free cash flow did CENTRAL GARDEN & PET CO generate in fiscal 2025?

Cash from operations of $332.5M minus capital expenditures of $41.4M left free cash flow of $291.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CENTRAL GARDEN & PET CO